Drug Type Biosimilar, Fusion protein |
Synonyms Etanercept biosimilar |
Target |
Mechanism LTα inhibitors(Tumor necrosis factor β inhibitors), TNF-α inhibitors(Tumor necrosis factor α inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rheumatoid Arthritis | Phase 1 | KR | 01 Sep 2012 |
Not Applicable | Arthritis, Psoriatic First line | 54 | Etanercept originator | (gwifizcqfw) = gofhwurtrs akcphulqll (ttlciuharm ) View more | - | 31 May 2023 | |
(gwifizcqfw) = jizmxwcbhr akcphulqll (ttlciuharm ) View more | |||||||
Not Applicable | - | 187 | (peumushghx) = kzfrsfuias sjlriiyxji (qhforkztqa ) View more | Positive | 02 Jun 2021 | ||
Not Applicable | - | Originator etanercept | (kdaqnpgnec) = caycmuakql glotrxbuqt (thmbdzzgnw ) | Negative | 03 Jun 2020 | ||
(kdaqnpgnec) = oklxmjoiee glotrxbuqt (thmbdzzgnw ) | |||||||
Not Applicable | - | 235 | Etanercept original | (rjwovkluaf) = fcsbrprbkr kjaktnhwdv (zeclgppbtf ) View more | Negative | 03 Jun 2020 | |
(niaovxqzbm) = ucpyqkvlto medzqqciot (tvguxbgwvm ) | |||||||
Not Applicable | 100 | (veeikecemx) = 9.4% bxajtbciys (qzecxhrmgp ) View more | - | 03 Jun 2020 | |||
Not Applicable | - | - | (prghehrqbv) = cilkrsdpak uqvrkhsqmj (zhdlbhhrfs ) View more | - | 12 Jun 2019 | ||
(prghehrqbv) = tusogpwfwe uqvrkhsqmj (zhdlbhhrfs ) View more |